PUBLISHER: Global Market Insights Inc. | PRODUCT CODE: 2109159
PUBLISHER: Global Market Insights Inc. | PRODUCT CODE: 2109159
Fish Oil Concentration and Refinement Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2026 - 2035
The Global Fish Oil Concentration & Refinement Market was valued at USD 2.6 billion in 2025 and is estimated to grow at a CAGR of 6.8% to reach USD 5 billion by 2035.
Market expansion is driven by the growing global focus on preventive healthcare, increasing consumer preference for products that support cardiovascular and cognitive wellness, and stricter quality requirements governing omega-3 ingredients used across pharmaceutical and infant nutrition applications. The industry is also witnessing a gradual shift from conventional commodity-grade ethyl ester (EE) concentrates toward premium re-esterified triglyceride (rTG) and pharmaceutical-grade active pharmaceutical ingredient (API) formats, creating higher-value opportunities for manufacturers. Continuous improvements in purification technologies, expanding demand for premium-quality omega-3 formulations, rising investments in refining capabilities, and increasing emphasis on regulatory compliance are further supporting long-term industry growth. As manufacturers continue to prioritize higher-purity production and value-added formulations, the fish oil concentration & refinement market is expected to maintain steady momentum throughout the forecast period.
| Market Scope | |
|---|---|
| Start Year | 2025 |
| Forecast Year | 2026-2035 |
| Start Value | $2.6 Billion |
| Forecast Value | $5 Billion |
| CAGR | 6.8% |
The molecular distillation segment captured a 48% share in 2025 and is forecast to grow at a 6.2% CAGR. The process continues to lead the market because it consistently delivers ultra-high-purity omega-3 concentrates at commercial production scale while meeting stringent quality requirements established for pharmaceutical and specialized nutrition applications. Its proven ability to achieve reliable purification efficiency and product consistency makes molecular distillation the preferred refining technology across premium manufacturing operations.
The dietary supplements & nutraceuticals segment accounted for a 38% share in 2025 and is projected to grow at a CAGR of 6.5% through 2035, supported by strong demand across cardiovascular health, preventive wellness, immune support, and overall health management applications. Increasing consumer awareness regarding proactive healthcare and the growing preference for nutrition-based solutions are encouraging the adoption of supplements containing functional ingredients. Rising interest in maintaining heart health, improving lifestyle-related health outcomes, and addressing nutritional deficiencies is further driving product demand. In addition, expanding availability of personalized nutrition products, clean-label formulations, and innovative supplement formats is expected to strengthen segment growth over the forecast period.
North America Fish Oil Concentration & Refinement market held a 22% share in 2025, supported by a well-established dietary supplement industry with retail sales, along with a mature regulatory environment governing omega-3 pharmaceutical products and premium nutritional ingredients. Strong consumer awareness, advanced manufacturing capabilities, and sustained demand for high-quality refined fish oil products continue to reinforce the region's market position.
The competitive landscape of the Global Fish Oil Concentration & Refinement Market includes BASF SE, dsm-firmenich, Epax Norway AS, KD Pharma Group SA, Golden Omega, GC Rieber VivoMega AS, Polaris, OLVEA Fish Oils, Lysi hf, Croda International, KinOmega Biopharm, Sinomega Biotech Engineering Co., Ltd., Wiley Companies / AlaskOmega, Aker BioMarine Antarctic AS, and Nissui Pharmaceutical Co., Ltd. These companies operate across pharmaceutical-grade, premium nutraceutical, and commodity-grade fish oil concentration segments, serving diverse customer requirements throughout the global value chain. Companies participating in the Global Fish Oil Concentration & Refinement Market are strengthening their market position by expanding production capacity, improving purification technologies, and investing in advanced concentration processes that deliver higher-quality omega-3 ingredients. Manufacturers are increasing their focus on pharmaceutical-grade and premium nutraceutical product portfolios to address growing demand for high-purity formulations. Many companies are also enhancing regulatory compliance capabilities and obtaining internationally recognized quality certifications to improve customer confidence and expand access to regulated markets. Strategic partnerships with raw material suppliers, long-term sourcing agreements, and investments in reliable feedstock procurement infrastructure are helping improve supply chain stability. In addition, businesses are emphasizing research and development, process optimization, proprietary refining technologies, and product innovation to differentiate their offerings, strengthen competitive positioning, increase operational efficiency, and create sustainable long-term growth opportunities across global pharmaceutical and nutrition markets.
Table of Contents
Chapter 1 Methodology & Scope
- 1.1 Market scope and definition
- 1.2 Research design
- 1.2.1 Research approach
- 1.2.2 Data collection methods
- 1.3 Data mining sources
- 1.3.1 Global
- 1.3.2 Regional/Country
- 1.4 Base estimates and calculations
- 1.4.1 Base year calculation
- 1.4.2 Key trends for market estimation
- 1.5 Primary research and validation
- 1.5.1 Primary sources
- 1.6 Forecast model
- 1.7 Research assumptions and limitations
Chapter 2 Executive Summary
- 2.1 Industry 360° synopsis
- 2.2 Key market trends
- 2.2.1 Concentration & Refinement Technology
- 2.2.2 Output Product Form
- 2.2.3 Application
- 2.2.4 Source Species
- 2.2.5 Regional
- 2.3 TAM Analysis, 2026-2035
- 2.4 CXO perspectives: Strategic imperatives
- 2.5 Future outlook and strategic recommendations
Chapter 3 Industry Insights
- 3.1 Industry ecosystem analysis
- 3.1.1 Supplier landscape
- 3.1.2 Profit margin
- 3.1.3 Value addition at each stage
- 3.1.4 Factor affecting the value chain
- 3.1.5 Disruptions
- 3.2 Industry impact forces
- 3.2.1 Growth drivers
- 3.2.2 Industry pitfalls and challenges
- 3.2.3 Market opportunities
- 3.3 Growth potential analysis
- 3.4 Regulatory landscape
- 3.4.1 North America
- 3.4.2 Europe
- 3.4.3 Asia Pacific
- 3.4.4 Latin America
- 3.4.5 Middle East & Africa
- 3.5 Porter’s analysis
- 3.6 PESTEL analysis
- 3.7 Technology and innovation landscape
- 3.7.1 Current technological trends
- 3.7.2 Emerging technologies
- 3.8 Price trends
- 3.8.1 By region
- 3.8.2 By Concentration & Refinement Technology
- 3.9 Future market trends
- 3.10 Patent landscape
- 3.11 Trade statistics (HS code)
- 3.11.1 Major importing countries
- 3.11.2 Major exporting countries
- 3.12 Sustainability and environmental aspects
- 3.12.1 Sustainable practices
- 3.12.2 Waste reduction strategies
- 3.12.3 Energy efficiency in production
- 3.12.4 Eco-friendly initiatives
Chapter 4 Competitive Landscape, 2025
- 4.1 Introduction
- 4.2 Company market share analysis
- 4.2.1 By region
- 4.2.1.1 North America
- 4.2.1.2 Europe
- 4.2.1.3 Asia Pacific
- 4.2.1.4 LATAM
- 4.2.1.5 MEA
- 4.2.1 By region
- 4.3 Company matrix analysis
- 4.4 Competitive analysis of major market players
- 4.5 Competitive positioning matrix
- 4.6 Key developments
- 4.6.1 Mergers & acquisitions
- 4.6.2 Partnerships & collaborations
- 4.6.3 New product launches
- 4.6.4 Expansion plans
Chapter 5 Market Estimates and Forecast, By Concentration & Refinement Technology, 2022–2035 (USD Million) (Kilo Tons)
- 5.1 Key trends
- 5.2 Molecular Distillation
- 5.2.1 Short-Path Molecular Distillation
- 5.2.2 Wiped-Film Molecular Distillation
- 5.3 Enzymatic Processing
- 5.3.1 Enzymatic Transesterification (EE)
- 5.3.2 Enzymatic Re-esterification (rTG)
- 5.3.3 Enzymatic Hydrolysis (FFA)
- 5.4 Urea Complexation
- 5.5 Supercritical Fluid Extraction (SFE)
- 5.6 Membrane-Based Filtration
- 5.7 Winterization & Fractional Crystallization
- 5.8 Others (Chromatographic, Hybrid)
Chapter 6 Market Estimates and Forecast, By Output Product Form, 2022–2035 (USD Million) (Kilo Tons)
- 6.1 Key trends
- 6.2 Ethyl Ester (EE)
- 6.2.1 Standard Concentrate (30–50%)
- 6.2.2 High Concentrate (50–70%)
- 6.2.3 Ultra-High/Pharma Grade (>70%)
- 6.3 Re-esterified Triglyceride (rTG)
- 6.3.1 Standard rTG
- 6.3.2 Premium rTG (>90% TG)
- 6.4 Natural Triglyceride (TG)
- 6.5 Phospholipid
- 6.6 Others
Chapter 7 Market Estimates and Forecast, By Application, 2022–2035 (USD Million) (Kilo Tons)
- 7.1 Key trends
- 7.2 Dietary Supplements & Nutraceuticals
- 7.2.1 Cardiovascular Health
- 7.2.2 Cognitive & Brain Health
- 7.2.3 Joint & Inflammation Support
- 7.2.4 General Wellness
- 7.3 Pharmaceuticals & Clinical Nutrition
- 7.3.1 Prescription Omega-3 APIs
- 7.3.2 Clinical/Enteral/Parenteral
- 7.4 Food & Beverage Fortification
- 7.4.1 Functional Foods
- 7.4.2 Fortified Beverages
- 7.4.3 Bakery & Dairy Fortification
- 7.5 Infant & Maternal Nutrition
- 7.5.1 Infant Formula
- 7.5.2 Prenatal & Maternal Supplements
- 7.6 Animal Feed & Aquaculture
- 7.6.1 Aquaculture Feed
- 7.6.2 Livestock & Poultry Feed
- 7.7 Pet Food & Veterinary Nutrition
- 7.8 Others
Chapter 8 Market Estimates and Forecast, By Source Species, 2022–2035 (USD Million) (Kilo Tons)
- 8.1 Key trends
- 8.2 Anchovy/Anchoveta
- 8.3 Sardine/Pilchard
- 8.4 Mackerel
- 8.5 Salmon & Salmonids
- 8.6 Herring
- 8.7 Tuna
- 8.8 Others (Cod, Menhaden, Pollock)
Chapter 9 Market Estimates and Forecast, By Region, 2022–2035 (USD Million) (Kilo Tons)
- 9.1 Key trends
- 9.2 North America
- 9.2.1 U.S.
- 9.2.2 Canada
- 9.3 Europe
- 9.3.1 Germany
- 9.3.2 UK
- 9.3.3 France
- 9.3.4 Spain
- 9.3.5 Italy
- 9.3.6 Rest of Europe
- 9.4 Asia Pacific
- 9.4.1 China
- 9.4.2 India
- 9.4.3 Japan
- 9.4.4 Australia
- 9.4.5 South Korea
- 9.4.6 Rest of Asia Pacific
- 9.5 Latin America
- 9.5.1 Brazil
- 9.5.2 Mexico
- 9.5.3 Argentina
- 9.5.4 Rest of Latin America
- 9.6 Middle East and Africa
- 9.6.1 Saudi Arabia
- 9.6.2 South Africa
- 9.6.3 UAE
- 9.6.4 Rest of Middle East and Africa
Chapter 10 Company Profiles
- 10.1 BASF SE
- 10.2 dsm-firmenich
- 10.3 Epax Norway AS
- 10.4 KD Pharma Group SA
- 10.5 Golden Omega
- 10.6 GC Rieber VivoMega AS
- 10.7 Polaris
- 10.8 OLVEA Fish Oils
- 10.9 Lysi hf
- 10.10 Croda International
- 10.11 KinOmega Biopharm
- 10.12 Sinomega Biotech Engineering Co., Ltd.
- 10.13 Wiley Companies / AlaskOmega
- 10.14 Aker BioMarine Antarctic AS
- 10.15 Nissui Pharmaceutical Co., Ltd.
